A phase 1 study of XL019 a selective JAK2 inhibitor, in patients with primary myelofibrosis and, post-polycythemia vera/essential thrombocythemia myelofibrosis

被引：12
|
作者：
Verstovsek, Srdan [1 ]
Pardanani, Animesh D. [2 ]
Shah, Neil P. [3 ]
Sokol, Lubomir [4 ]
Wadleigh, Martha [5 ]
Gilliland, D. Gary
List, Alan F. [4 ]
Tefferi, Ayalew [2 ]
Kantarjian, Hagop M. [1 ]
Bui, Lynne A. [6 ]
Clary, Douglas O. [6 ]
机构：
[1] MD Anderson Canc Ctr, San Francisco, CA USA
[2] Mayo Clin, San Francisco, CA USA
[3] Univ Calif San Francisco, San Francisco, CA USA
[4] H Lee Moffitt Canc Ctr & Res Inst, San Francisco, CA USA
[5] Dana Farber Canc Inst, San Francisco, CA USA
[6] Exelixis Inc, San Francisco, CA USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.553.553
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
553
引用
收藏
页码：170A / 170A
页数：1
相关论文
共 50 条
  • [21] A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)
    Mascarenhas, John
    Sandy, Lonette
    Lu, Min
    Yoon, James
    Petersen, Bruce
    Zhang, David
    Ye, Fei
    Newsom, Carrie
    Najfeld, Vesna
    Hochman, Tsivia
    Goldberg, Judith D.
    Hoffman, Ronald
    LEUKEMIA RESEARCH, 2017, 53 : 13 - 19
  • [22] RUXOLITINIB PLUS PANOBINOSTAT IN PATIENTS WITH PRIMARY MYELOFIBROSIS, POST-POLYCYTHEMIA VERA MYELOFIBROSIS OR POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS: A PHASE 1B DOSE-FINDING STUDY
    Vannucchi, A. M.
    Heidel, F. H.
    Ribrag, V.
    Kiladjian, J. J.
    Passamonti, F.
    Hayat, A.
    Conneally, E.
    Kindler, T.
    Martino, B.
    Lipka, D. B.
    Acharyya, S.
    Gopalakrishna, P.
    Loechner, S.
    Mu, S.
    Harrison, C. N.
    HAEMATOLOGICA, 2014, 99 : 129 - 130
  • [23] Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis
    A Tefferi
    L Saeed
    C A Hanson
    R P Ketterling
    A Pardanani
    N Gangat
    Leukemia, 2017, 31 : 2851 - 2852
  • [24] Do Patients with Post-Essential Thrombocythemia and Post-Polycythemia Vera Differ from Patients with Primary Myelofibrosis?
    Masarova, Lucia
    Daver, Naval
    Pemmaraju, Naveen
    Bose, Prithviraj
    Pierce, Sherry
    Manshouri, Taghi
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    BLOOD, 2015, 126 (23)
  • [25] Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis
    Tefferi, A.
    Saeed, L.
    Hanson, C. A.
    Ketterling, R. P.
    Pardanani, A.
    Gangat, N.
    LEUKEMIA, 2017, 31 (12) : 2851 - 2852
  • [26] A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)
    Mascarenhas, J.
    Marcellino, B. K.
    Lu, M.
    Kremyanskaya, M.
    Fabris, F.
    Sandy, L.
    Mehrotra, M.
    Houldsworth, J.
    Najfeld, V.
    El Jamal, S.
    Petersen, B.
    Moshier, E.
    Hoffman, R.
    LEUKEMIA RESEARCH, 2020, 88
  • [27] Efficacy and safety of JAK inhibitor INC424 in patients with primary and post-polycythemia vera or post-essential thrombocythemia myelofibrosis in the Chinese population
    Xin Du
    Daobin Zhou
    Frontiers of Medicine, 2016, 10 : 437 - 443
  • [28] Efficacy and safety of JAK inhibitor INC424 in patients with primary and post-polycythemia vera or post-essential thrombocythemia myelofibrosis in the Chinese population
    Xin Du
    Daobin Zhou
    Frontiers of Medicine, 2016, 10 (04) : 437 - 443
  • [29] Efficacy and safety of JAK inhibitor INC424 in patients with primary and post-polycythemia vera or post-essential thrombocythemia myelofibrosis in the Chinese population
    Du, Xin
    Zhou, Daobin
    FRONTIERS OF MEDICINE, 2016, 10 (04) : 437 - 443
  • [30] Solid Tumors in Post-Polycythemia Vera and Post-Essential Thrombocythemia Myelofibrosis: A Study on 2220 Patients
    Mora, Barbara
    Rumi, Elisa
    Guglielmelli, Paola
    Barraco, Daniela
    Maffioli, Margherita
    Rambaldi, Alessandro
    Caramella, Marianna
    Komrokji, Rami S.
    Gotlib, Jason R.
    Kiladjian, Jean-Jacques
    Cervantes, Francisco
    Devos, Timothy
    Palandri, Francesca
    De Stefano, Valerio
    Ruggeri, Marco
    Silver, Richard T.
    Benevolo, Giulia
    Albano, Francesco
    Cavalloni, Chiara
    Pietra, Daniela
    Barbui, Tiziano
    Rotunno, Giada
    Cazzola, Mario
    Vannucchi, Alessandro M.
    Giorgino, Toni
    Passamonti, Francesco
    BLOOD, 2018, 132
12345